Liraglutide Investigated for Reducing Opioid Craving and Relapse in Opioid Use Disorder
Use of a GLP-1R Agonist to Treat Opioid Use Disorder
Abstract
Liraglutide is being studied to assess its safety and efficacy in reducing opioid craving and preventing early relapse in patients with opioid use disorder.